| Document |
Document Title |
|
WO/2015/099126A1 |
A method for producing (2S,5S)/(2R,5R)-5-hydroxypiperidine-2-carboxylic acid indicated by formula (10), the method being characterized in including a step for removing protection from hydroxyl groups in a compound represented by formula ...
|
|
WO/2015/093580A1 |
[Problem] To provide a non-aqueous electrolyte solution having an excellent cycle capacity retention rate and low-temperature resistance characteristics, and a non-aqueous electrolyte rechargeable battery that uses the non-aqueous electr...
|
|
WO/2015/085522A1 |
A process for preparing alkanesulphonic acids from dialkyl disulphides with nitric acid and oxygen is provided.
|
|
WO/2015/087797A1 |
Provided is a composition comprising: a charge-transporting substance that comprises N,N'-diphenylbenzidine; an electron-accepting dopant substance; and an organic solvent. This composition is suitable, for example, as a composition for ...
|
|
WO/2015/082847A1 |
The invention relates to a method for the industrial synthesis of the compound of formula (I).
|
|
WO/2015/078903A1 |
The invention relates to a cosmetic process for lightening and/or bleaching the skin, comprising the topical application of a composition comprising an optical brightener neutralized with an ammonium salt, and to a makeup and/or care pro...
|
|
WO/2015/077451A1 |
The present invention relates to N-phenyl carbamate derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide 2 receptor.
|
|
WO/2015/072290A1 |
Provided is a method for producing a mono active ester in a simple and selective manner using a 1,2,3-triol as a raw material. In a method for producing a 1,2,3-triol optically active monoester compound according to the present invention...
|
|
WO/2015/071455A1 |
A compound of the formula (I) ALK-SO2-O-O-SO2OX, wherein ALK is a branched or unbranched alkyl group, especially a methyl, ethyl, propyl, butyl, isopropyl, isobutyl group, or a higher alkyl group, and X = hydrogen, zinc, aluminium, an al...
|
|
WO/2015/071365A1 |
A process for preparing alkanesulfonic acids from sulfur trioxide and an alkane, wherein sulfur trioxide, the alkane and dialkylsulfonoyi peroxide (DASP) react as components, characterized in that the following steps are performed : a) s...
|
|
WO/2015/073882A1 |
A styrene based water soluble polymer containing pendant sulfonated calix[4]arene groups has been synthesized by using free radical polymerization combined with post-polymerization sulfonation chemistry. The monomer 25-(4-vinylbenzyl)-26...
|
|
WO/2015/064711A1 |
The purpose of the present invention is to provide a production method by which a methylene disulfonyl chloride compound can be obtained with a high yield using an industrially advantageous method in which the usage quantity of phosphory...
|
|
WO/2015/064787A1 |
The present invention provides an extinction dye of an anthraquinone structure, wherein the extinction dye has a broad and high absorption spectrum in a visible ray and near-infrared wavelength region and shows high stability and excelle...
|
|
WO/2015/064712A1 |
The purpose of the present invention is to efficiently produce a methylene-disulfonic acid compound by using a carboxylic acid chloride compound and by using an industrially advantageous method. Provided is a method for producing a methy...
|
|
WO/2015/055251A1 |
A method and a plant for ageing a liquid post-sulfonation reaction mixture comprising linear alkylbenzenesulfonic acid and unreacted linear alkylbenzene using a system of two or more stirred tank reactors which are operated in cycles in ...
|
|
WO/2015/053320A1 |
Provided is an arylsulfonic acid compound characterized by being represented by formula (1). [In the formula, Ar1 represents a group represented by formula (2) (in formula (2), R1 to R5 each independently represent a hydrogen atom, halog...
|
|
WO/2015/051597A1 |
Methods for preparing intermediates of SGLT2 inhibitors are provided, including crystalline forms and methods of crystallizing intermediates.
|
|
WO/2015/044177A1 |
The present invention refers to compounds of formula: (formula A), wherein R1 is selected from (formula I), (formula II), (formula (III), (formula IV), (formula V), or (formula B), and wherein R2, R3, R4 and R5 are as defined in the clai...
|
|
WO/2015/047105A1 |
The present invention relates to novel compounds of polyfunctionalized polyethylene and polypropylene glycols, their synthesis and their use, in particular as tracers in applications related to oil and gas production, and especially as s...
|
|
WO/2015/045977A1 |
The present invention provides: an active light-sensitive or radiation-sensitive resin composition allowing pattern formation, in which pattern collapse is suppressed when used for negative development, and an excellent pattern profile i...
|
|
WO/2015/025859A1 |
A radiation-sensitive resin composition that comprises a polymer having an acid-dissociable group-containing structural unit, a compound comprising a radiolytic onium cation and a counter anion, and a solvent, wherein the counter anion h...
|
|
WO/2015/025826A1 |
The purpose of the present invention is to provide: a novel substituted phenyl ether compound which has a control effect against pests; and a pest control agent which contains this substituted phenyl ether compound as an active ingredien...
|
|
WO/2015/013865A1 |
Disclosed are agomelatine sulfonic acids complexes having the specific stoichiometry of 2 molar equivalents of agomelatine for 1 molar equivalent of sulfonic acids. Those complexes show excellent solubility, stability and purity, making ...
|
|
WO/2015/013903A1 |
The present invention relates to the p-toluenesulfonic acid co-crystals of agomelatine of formula (I), preparation and use thereof, and to pharmaceutical composition containing it. The p-toluenesulfonic acid co-crystals of agomelatine ob...
|
|
WO/2015/013187A1 |
The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes, obesity, hypertension, dyslipidemia, a neuro...
|
|
WO/2015/007206A1 |
The present invention relates to novel afatinib acid addition salts and crystal forms thereof. Compared with the prior art, the afatinib acid addition salts and crystal forms thereof of the present invention have one or more improved pro...
|
|
WO/2015/005051A1 |
Provided are a compound and an active light sensitive or radiation sensitive resin composition, which are capable of forming an ultrafine pattern (for example, one having a line width of 50 nm or less), while satisfying high sensitivity,...
|
|
WO/2015/005351A1 |
Provided is a cyclic azine compound which has excellent heat resistance and can be used in an electron transport material that has an excellent effect of prolonging the service life of an organic electroluminescent element or increasing ...
|
|
WO/2015/001020A1 |
The preparation of a compound of formula (I) comprising an -SO2F function by reacting a compound of formula (II) with a fluorinating agent chosen from hydrofluoric acid and an ionic fluoride of a monovalent or divalent cation is describe...
|
|
WO/2014/209711A1 |
Processes to prepare lightly branched surfactant products comprise combining at least one olefin and a coordination-insertion catalyst under conditions such that at least one oligomer product is formed. The surfactant products comprise a...
|
|
WO/2014/198164A1 |
The present invention relates to the field of medicinal chemistry, specifically to a cis-benzylisoquinoline compound (I), a preparation method therefor, a pharmaceutical preparation containing said compound and medical uses thereof. The ...
|
|
WO/2014/198902A1 |
The present invention relates to an implantable material having at least one external surface grafted with a film comprising carboxylate and sulfonate functions wherein the film is simultaneously synthesized and grafted directly on said ...
|
|
WO/2014/200937A1 |
The present invention provides processes for making 2-((3R,5R,6S)-5-(3- chlorophenyl)-6-(4-chlorophenyl)-l-((S)-l-(isopropylsulfonyl
)-3-methylbutan-2-yl)-3- methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates and processes f...
|
|
WO/2014/194690A1 |
Disclosed is a method for purifying acrylamide alkyl sulfonic acid. The method comprises the following steps: (1) evenly mixing to a material A and a solvent C to be contacted, an amount of the material A exceeding a dissolvability in th...
|
|
WO/2014/175359A1 |
A method for producing an olefin, wherein a starting material alcohol is subjected to a dehydration reaction in the presence of an acid catalyst. The acid catalyst contains a metal oxide. The starting material alcohol is composed of two ...
|
|
WO/2014/171398A1 |
Provided is a method for producing an alkyl-benzene composition and an alkyl benzene sulfonate which makes it possible to improve the hue of a linear alkyl benzene sulfonate to be used as a cleaning agent. This alkyl-benzene composition ...
|
|
WO/2014/171894A1 |
The present invention provides a method of synthesizing a cyclic carbonate comprising the step of reacting an alcohol with carbon dioxide.in the presence of a base.
|
|
WO/2014/155103A1 |
The invention discloses spray-dried compositions for inhalation and methods for preparing such powder compositions. The compositions of the invention are produced by spray-drying taurine under conditions that (i) retain the physical and ...
|
|
WO/2014/157534A1 |
An electrolytic solution for non-aqueous secondary batteries which includes at least one specific aromatic compound selected from (A) and (B), an electrolyte, and an organic solvent. (A) An aromatic compound having three or more fused or...
|
|
WO/2014/157653A1 |
The present invention addresses the problem of providing an efficient process for preparing important intermediate compounds (1) and (1a) for the production of FXa inhibitors (X) and (X-a). The present invention pertains to: a process wh...
|
|
WO/2014/157676A1 |
Provided is a novel vinyl-group-containing fluorene compound and a method for producing the same, a polymerizable monomer and cross-linking agent comprising this compound, a leaving-group-containing fluorene compound, a monovinyl-group-c...
|
|
WO/2014/154963A1 |
The invention concerns sulfonate compounds with the following formula (I): in which: R2 represents an ethyl group, an n-propyl group or an isopropyl group; when R2 is an ethyl group, R1 is an ethyl group, an n-propyl group or an n-butyl ...
|
|
WO/2014/149306A1 |
The present disclosure provides chemical compositions useful for minimizing or preventing the precipitation of sludge, such as asphaltenes, maltenes, or similar asphaltic components, during an acidizing treatment. Methods for preventing ...
|
|
WO/2014/152494A1 |
The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
|
|
WO/2014/148435A1 |
This method involves dissolving a solid substance containing α-sulfo fatty acid alkyl ester salt in water of a temperature Ts(°C) to produce an aqueous solution of the α-sulfo fatty acid alkyl ester salt, wherein the heat absorption p...
|
|
WO/2014/150171A1 |
Novel poly-branched, mono- or poly-unsaturated functional materials are provided. More specifically, certain novel unsaturated branched functional compositions are provided that are made via isoprenoids and/or isoprenoid derivatives whic...
|
|
WO/2014/145068A1 |
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for incre...
|
|
WO/2014/141979A1 |
The present invention is a radiation-sensitive resin composition which contains a radiation-sensitive acid generator and a polymer having a structural unit that contains an acid-cleavable group, and wherein the radiation-sensitive acid g...
|
|
WO/2014/126167A1 |
The present invention addresses the problem of providing a colored composition having higher heat resistance compared with conventional colored compositions. The present invention relates to: "a polymer having a monomer unit derived from...
|
|
WO/2014/125940A1 |
Provided are an internal olefin sulfonate composition that can sufficiently heighten foaming properties, foam lightness, and foam disappearance properties, and a cleaning agent composition that includes an internal olefin sulfonate. The ...
|
